Bio-Tech Stocks You Don’t Wanna Miss - Part I
Current YTD Retuen: -$1623
Biotechnology stocks are typically intimidated by investors due to its nature of vulnerability around the drugs the companies produce. With the exception of well known behemoth companies like Amgen (AMGN) and Genentech (DNA) , many biotech companies can plummet in value if one of their main drugs fail to go through. Having worked for a pharmaceutical company before (McNeil - one of Johnson and Johnson’s companies), I know how tough it can be to get a drug approved by FDA, not to mention the risk of side effects harming the company’s reputation (e.g. Merck (MRK) and its drug Vioxx back in 2004). (more…)
